Addex Therapeutics ADXN Growth Metrics (2018-2026)

NASDAQ ADXN
$3.61 -0.09 (-2.43%)
At close: Sep 9, 2026 · 4:00 PM EDT
Reported Financials

Addex Therapeutics Quarterly Growth Metrics

Periods 30 quarters
Latest Mar 2026

Addex Therapeutics growth metrics data for the quarter ended Mar 2026. These growth metrics cover 30 quarters of results from Dec 2018 through Mar 2026, standardized by Business Quant from the company’s SEC filings.

Growth Metrics Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Growth Ratios
EBITDA Margin Growth (1y)
-0.01M1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.38M0.08M0.20M-0.03M-0.07M-0.09M-18.12M-0.12M-13.15M
EBITDA Margin Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M0.03M1.12M-0.11M0.00M-0.03M-0.06M-18.22M-0.13M-31.08M
EBITDA Margin Growth (5y)
-0.08M-0.16M-0.04M-18.13M0.91M-31.39M
EBITDA Margin (QoQ)
-0.01M-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M0.00M-0.02M-0.12M0.11M-0.04M-0.04M-18.15M-31.19M
EBIT Margin Growth (1y)
-0.01M1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.38M0.08M0.20M-0.03M-0.07M-0.09M-18.12M-0.12M-13.15M
EBIT Margin Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M0.03M1.12M-0.11M0.00M-0.03M-0.06M-18.22M-0.13M-31.08M
EBIT Margin Growth (5y)
-0.08M-0.16M-0.04M-18.13M0.91M-31.39M
EBIT Margin (QoQ)
-0.01M-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M0.00M-0.02M-0.12M0.11M-0.04M-0.04M-18.15M-31.19M
EBT Margin Growth (1y)
-0.01M1.16M0.02M-0.21M-0.35M-0.05M0.12M0.24M0.39M0.08M-0.17M0.01M-0.12M-0.26M-7.83M-0.25M-66.04M
EBT Margin Growth (3y)
-0.29M-0.48M-0.03M0.25M0.04M0.03M1.19M-0.03M0.03M-0.08M-0.23M-7.88M-0.43M-74.04M
EBT Margin Growth (5y)
-0.04M-0.21M-0.21M-7.75M0.68M-73.90M
EBT Margin (QoQ)
-0.02M-0.01M0.04M-0.23M-0.15M0.29M0.21M-0.11M-878.00-0.01M-0.04M0.06M-0.13M-0.16M-7.61M-73.40M
FCF Margin Growth (1y)
0.01M0.90M-0.02M-0.17M-0.25M-0.03M-0.23M0.16M0.27M-0.00M-0.24M-0.05M-0.20M-0.01M18.75M-0.11M-43.20M
FCF Margin Growth (3y)
-0.24M-0.36M0.21M-0.19M-0.00M0.03M0.87M-0.49M-0.06M-0.17M-0.04M18.27M-0.11M-24.70M
FCF Margin Growth (5y)
-0.13M-0.28M0.21M18.32M0.76M-24.94M
FCF Margin (QoQ)
-0.03M0.03M-0.01M-0.16M-0.11M0.25M-0.21M0.23M0.00M-0.03M-0.45M0.43M-0.15M0.17M18.30M-24.80M
Interest Coverage Ratio Growth (1y)Interest Cover Growth (1y)
-1,101.99%2,214.60%8,240.34%-38.01%72.07%-120.89%-92.15%-84.96%105.21%59.66%-90.50%5,467.39%-63.60%272.98%-2,359.01%-95.98%-12,181.63%-98.37%297.56%470.43%
Interest Coverage Ratio Growth (3y)Interest Cover Growth (3y)
535.35%7.29%-34.23%-35.92%16.31%-43.31%-47.36%-58.08%-14.64%73.15%26.10%-47.38%-29.43%-30.45%-31.84%26.23%61.86%133.67%
Interest Coverage Ratio Growth (5y)Interest Cover Growth (5y)
12.79%13.85%59.56%-61.98%-18.65%-40.00%-16.43%-53.11%-44.00%94.39%3.54%
Interest Coverage Ratio (QoQ)Interest Cover (QoQ)
-229.43%282.21%363.57%-94.33%-158.32%-36.25%274.20%-89.13%-79.80%-1,154.75%141.03%6,267.66%-99.87%4,911.87%-635.88%111.32%-497.22%100.68%64,712.78%-67.30%
Net Margin Growth (1y)
0.00M0.06M0.02M0.06M0.02M0.00M0.03M-0.03M-0.03M-0.00M-0.01M-0.00M1.12M-0.73M64.10M39.77M-275.40M
Net Margin Growth (3y)
0.03M-0.06M0.07M-0.16M-0.00M491.000.05M0.04M0.03M1.12M-0.73M64.12M39.04M-211.32M
Net Margin Growth (5y)
0.00M1.03M-0.66M63.93M39.10M-211.27M
Net Margin (QoQ)
0.03M-60.000.05M-0.03M-0.00M-0.02M0.08M-0.08M-0.00M0.00M0.08M-0.08M1.12M-1.85M64.90M-250.28M
Operating Margin Growth (1y)
-0.01M1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.38M0.08M0.20M-0.03M-0.07M-0.09M-18.12M-0.12M-13.15M
Operating Margin Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M0.03M1.12M-0.11M0.00M-0.03M-0.06M-18.22M-0.13M-31.08M
Operating Margin Growth (5y)
-0.08M-0.16M-0.04M-18.13M0.91M-31.39M
Operating Margin (QoQ)
-0.01M-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M0.00M-0.02M-0.12M0.11M-0.04M-0.04M-18.15M-31.19M
Return on Assets [ROA] Growth (1y)ROA Growth (1y)
41.00-551.000.00M-40.00-0.00M-0.01M-0.00M0.00M0.01M0.02M-0.02M-0.03M0.00M-562.000.03M0.04M-0.01M0.14M0.15M0.19M
Return on Assets [ROA] Growth (3y)ROA Growth (3y)
-886.000.01M0.01M-0.02M-0.03M0.01M0.01M0.01M0.02M0.01M0.16M0.17M0.20M
Return on Assets [ROA] Growth (5y)ROA Growth (5y)
0.01M362.000.16M0.17M0.20M
Return on Assets [ROA] (QoQ)ROA (QoQ)
-494.00-0.00M0.00M-0.00M-0.01M-0.00M0.01M0.00M0.01M0.00M-0.03M-0.01M0.04M-0.00M0.01M-462.00-0.02M0.15M0.01M0.03M
Return on Capital Employed [ROCE] Growth (1y)ROCE Growth (1y)
-347.00-0.00M-0.00M-0.01M-0.02M-0.03M-0.04M-0.05M-0.01M0.01M0.04M0.00M0.04M0.03M0.01M0.06M238.00-0.00M-99.00-697.00
Return on Capital Employed [ROCE] Growth (3y)ROCE Growth (3y)
-0.06M-0.03M-0.02M-0.00M-0.05M0.00M0.01M0.01M0.01M0.03M0.04M0.05M0.06M
Return on Capital Employed [ROCE] Growth (5y)ROCE Growth (5y)
0.00M0.00M0.01M0.01M0.01M
Return on Capital Employed [ROCE] (QoQ)ROCE (QoQ)
25.00-0.00M-0.00M-0.00M-0.01M-0.01M-0.01M-0.02M0.02M0.01M0.02M-0.05M0.06M0.00M-931.00-706.00-584.00-747.000.00M-0.00M
Return on Sales [ROS] Growth (1y)ROS Growth (1y)
-0.01M1.09M-0.02M-0.21M-0.34M-0.05M-0.30M0.24M0.38M0.08M0.20M-0.03M-0.07M-0.09M-18.12M-0.21M-0.12M-13.15M
Return on Sales [ROS] Growth (3y)ROS Growth (3y)
-0.29M-0.47M-0.03M-0.21M0.04M0.03M1.12M-0.11M0.00M-0.03M-0.06M-18.22M0.10M-0.13M-31.08M
Return on Sales [ROS] Growth (5y)ROS Growth (5y)
-0.08M-0.16M-0.04M-18.13M-0.25M0.91M-31.39M
Return on Sales [ROS] (QoQ)ROS (QoQ)
-0.01M-0.01M0.00M-0.19M-0.14M0.29M-0.24M0.34M0.00M-0.02M-0.12M0.11M-0.04M-0.04M-18.15M0.05M-31.19M